This CDMO Firm Is Building in the Right Places
Custom synthesis growing 17%, peptides scaling, contrast media under long-term contracts Among India’s pharmaceutical API manufacturers, Divi’s Laboratories occupies a rare position — a company trusted by global innovators with complex, long-duration supply relationships that are difficult to replicate and even more difficult to dislodge. The fourth quarter of FY26 delivered a steady set of … Read more